4.5 Review

Factors and dosage formulations affecting the solubility and bioavailability of P-glycoprotein substrate drugs

Journal

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY
Volume 17, Issue 5, Pages 555-580

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/17425255.2021.1902986

Keywords

P-glycoprotein; solubility; bioavailability; supersaturation; spring-and-parachute approach; lipid-based formulations

Ask authors/readers for more resources

The expression of P-glycoprotein increases towards the distal small intestine, implying duodenum is the preferential absorption site for P-gp substrate drugs. The oral bioavailability of poorly soluble P-gp substrate drugs is low and varied but increases with high-fat meals. To attain high and steady oral bioavailability of poorly soluble P-gp substrate drugs, physicochemical modification of drugs or oral dosage formulations generating long-lasting supersaturation in the duodenum is preferred.
Introduction: Expression of P-glycoprotein (P-gp) increases toward the distal small intestine, implying that the duodenum is the preferential absorption site for P-gp substrate drugs. Oral bioavailability of poorly soluble P-gp substrate drugs is low and varied but increases with high-fat meals that supply lipoidal components and bile in the duodenum. Areas covered: Absorption properties of P-gp substrate drugs along with factors and oral dosage formulations affecting their solubility and bioavailability were reviewed with PubMed literature searches. An overview is provided from the viewpoint of the 'spring-and-parachute approach' that generates supersaturation of poorly soluble P-gp substrate drugs. Expert opinion: The oral bioavailability of P-gp substrate drugs is difficult to predict because of their low solubility, preferential absorption sites, and overlapping substrate specificities with CYP3A4, along with the scattered intestinal P-gp expression/function. To attain high and steady oral bioavailability of poorly soluble P-gp substrate drugs, physicochemical modification of drugs to improve solubility, or oral dosage formulations that generate long-lasting supersaturation in the duodenum, is preferred. In particular, supersaturable lipid-based drug delivery systems that can increase passive diffusion and/or lymphatic absorption are effective and applicable to many poorly soluble P-gp substrate drugs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available